Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation

Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation

Abstract Background Radiofrequency ablation (RFA) is considered a promising alternative to surgical excision for patients with small, unifocal early-stage breast cancer. A significant concern with the application of RFA in patients diagnosed with ductal carcinoma in situ (DCIS) via needle biopsy is...

Full description

Saved in:
Bibliographic Details
Main Authors: Hideo Shigematsu, Mutsumi Fujimoto, Kanako Suzuki, Haruka Ikejiri, Ai Amioka, Emiko Hiraoka, Shinsuke Sasada, Koji Arihiro, Morihito Okada
Format: Article
Language:English
Published: BMC 2025-02-01
Series:World Journal of Surgical Oncology
Subjects:
Radiofrequency ablation
DCIS
Needle biopsy
Underdiagnosis
Online Access:https://doi.org/10.1186/s12957-025-03697-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12957-025-03697-2

Similar Items